-
公开(公告)号：US20150147331A1
公开(公告)日：2015-05-28
申请号：US14489837
申请日：2014-09-18
Applicant: UCB PHARMA S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki , Simon Peter Tickle
IPC: C07K16/24
CPC classification number: C07K16/244 , A61K47/60 , A61K2039/505 , C07K16/464 , C07K2317/20 , C07K2317/24 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Abstract translation: 本发明涉及对IL-17的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途以及产生所述抗体分子的方法。
-
公开(公告)号：US20140044732A1
公开(公告)日：2014-02-13
申请号：US14035053
申请日：2013-09-24
Applicant: UCB Pharma S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
IPC: C07K16/24
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
3.发明授权公开(公告)号：US08617847B2
公开(公告)日：2013-12-31
申请号：US13632702
申请日：2012-10-01
Applicant: UCB Pharma S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
IPC: C12P21/08
CPC classification number: C07K16/468 , A61K39/3955 , C07K16/244 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Abstract translation: 本发明涉及对IL-17A和IL-17F的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途和产生所述抗体分子的方法。
-
公开(公告)号：US20130102030A1
公开(公告)日：2013-04-25
申请号：US13632702
申请日：2012-10-01
Applicant: UCB PHARMA S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
IPC: C07K16/46
CPC classification number: C07K16/468 , A61K39/3955 , C07K16/244 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Abstract translation: 本发明涉及对IL-17A和IL-17F的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途和产生所述抗体分子的方法。
-
公开(公告)号：US20170306052A1
公开(公告)日：2017-10-26
申请号：US15482260
申请日：2017-04-07
Applicant: UCB PHARMA S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
IPC: C07K16/46 , A61K39/395 , C07K16/24
CPC classification number: C07K16/468 , A61K39/3955 , C07K16/244 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
Patent Agency Ranking
公开(公告)号：US20160251429A1
公开(公告)日：2016-09-01
申请号：US15056956
申请日：2016-02-29
Applicant: UCB PHARMA S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki , Simon Peter Tickle
IPC: C07K16/24
CPC classification number: C07K16/244 , A61K47/60 , A61K2039/505 , C07K16/464 , C07K2317/20 , C07K2317/24 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Abstract translation: 本发明涉及对IL-17的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途以及产生所述抗体分子的方法。
-
公开(公告)号：US20130245229A1
公开(公告)日：2013-09-19
申请号：US13709055
申请日：2012-12-09
Applicant: UCB PHARMA S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki , Simon Peter Tickle
CPC classification number: C07K16/244 , A61K47/48215 , A61K47/60 , A61K2039/505 , C07K16/464 , C07K2317/20 , C07K2317/24 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
-
8.发明申请公开(公告)号：US20150322147A1
公开(公告)日：2015-11-12
申请号：US14706234
申请日：2015-05-07
Applicant: UCB Pharma S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
IPC: C07K16/24 , A61K39/395
CPC classification number: C07K16/468 , A61K39/3955 , C07K16/244 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Abstract translation: 本发明涉及对IL-17A和IL-17F的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途和产生所述抗体分子的方法。
-
公开(公告)号：US08865167B2
公开(公告)日：2014-10-21
申请号：US13709055
申请日：2012-12-09
Applicant: UCB Pharma S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki , Simon Peter Tickle
IPC: A61K39/395 , A61K39/00 , A61K47/48 , C07K16/24 , C07K16/46
CPC classification number: C07K16/244 , A61K47/48215 , A61K47/60 , A61K2039/505 , C07K16/464 , C07K2317/20 , C07K2317/24 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Abstract translation: 本发明涉及对IL-17的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途以及产生所述抗体分子的方法。
-
10.发明申请Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F 审中-公开编码结合IL-17A和IL-17F的抗体分子的核酸公开(公告)号：US20140186355A1
公开(公告)日：2014-07-03
申请号：US14107314
申请日：2013-12-16
Applicant: UCB Pharma S.A.
Inventor： Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
IPC: C07K16/24
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Abstract translation: 本发明涉及对IL-17A和IL-17F的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途和产生所述抗体分子的方法。
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.016 seconds)
